The Effect of BTK Inhibitor Ibrutinib on Leishmania infantum Infection In Vitro.

Ufuk MertCan MüftüoğluSevgi ErdemAygül SadıqovaSeray TozYusuf OzbelAyşe Caner

Published in: Acta parasitologica (2022)

Consequently, due to its efficacy and safety, Ibrutinib may be a promising candidate for the treatment of VL caused by L. infantum as a host-targeted drug.

Keyphrases

chronic lymphocytic leukemia
cancer therapy
emergency department
drug delivery